ÌÇÐÄÊÓÆµ

Velo

Velo

Velo

A leading global brand of Modern Oral nicotine pouches

Nicotine pouches placed under the lip so nicotine can be effectively absorbed.


What is Velo?

Ìý

Originating in Scandinavia, our flagship Modern Oral brand Velo is now a leading global brand of nicotine pouches. These typically appeal to a broader audience than traditional oral tobacco (snus) because of their attractive price positioning.

Nicotine pouches are small bags that are placed in the mouth between the upper lip and gum, which contain nicotine but no tobacco. They’re a modern and unobtrusive way for smokers and vapers to use nicotine. They also come in a variety of nicotine strengths and flavours to suit a variety of tastes and preferences.

The expansion of the Modern Oral category is driven by a specific set of unique benefits which compliments our New Categories portfolio. It combines discretion, which is important for today’s consumers, and satisfaction of nicotine and flavours in a unique format that can be used anytime, anywhere.

Strengthened by BAT’s proprietary nicotine delivery technology and unique design, our Modern Oral products offer a unique experience and outperform the competition on key attributes such as aroma, flavour and satisfaction.
Ìý

2024 highlights

Ìý

2024 was a year of further growth in volume (up 55.0% to 8.3 billion pouches) and value for Modern Oral with revenue up 46.6% to £790 million. Excluding the impact of foreign exchange, this was an increase of 51% in 2022.

We believe that Modern Oral is an exciting longer-term opportunity to unlock reduced risk products*† in Emerging Markets. We are particularly proud of Velo’s performance in the U.S., driven by the traction of our refreshed Velo brand expression and the Grizzly Modern Oral roll-out, and also Sweden, where Velo is the largest (by volume share) of any snus or Modern Oral nicotine pouch brand***.

*ÌýBased on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.

†ÌýOur products as sold in the U.S., including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.

Ìý

*** Top Oral and Modern Oral markets are defined as the Top markets by industry revenue, being the U.S., Sweden, Norway, Denmark, Switzerland, Poland and the UK and accounting for c. 90% of global industry Modern Oral revenue in 2023. The Top markets were updated in 2024, with a revision in 2023 volume share to 27.1% (Group) and 64.7% (AME). Also in 2024, the Group changed from Marlin to Retail Scan Data for the U.S. Modern Oral market, with the Group's Modern Oral volume share in 2023 rebased to 4.5%.